It does not kill bacteria
BPC-157 consists of a 15-amino acid sequence that interacts with cellular pathways involved in tissue repair and inflammation regulation
Despite its advantages, its important to acknowledge GHK-Cus limitations when compared to traditional acne treatments in a research context: Limited Direct Evidence for Active Acne Vulgaris: While it has anti-inflammatory properties, there is currently limited direct clinical evidence specifically demonstrating GHK-Cu as a primary treatment for active acne breakouts (e.g., reducing papules, pustules, or cysts)
When we studied the acute haemodynamic effects of BPC 157 on healthy rats, no changes were observed in gingival blood flow or in other investigated parameters even when BPC 157 was applied intravenously at 10 g/kg
The 0.05 mg/kg/day dose met the primary endpoint (p=0.007) while the higher 0.10 mg/kg/day dose did not (p=0.16) the basis for the approved dose
Microdermabrasion , may help improve the uppermost damaged layers of skin